-
4μ8C: Selective IRE1 RNase Inhibitor Guide
2026-08-23
4μ8C, also known as 7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde, is a selective IRE1α RNase inhibitor for mechanistic studies of the unfolded protein response. Product evidence supports its use in hypoxia and ER stress experiments, while its lack of reported antiproliferative activity and unfavorable pharmacokinetics limit therapeutic interpretation.
-
ERAD Hijacking for Transmembrane Protein Degradation
2026-08-22
Song et al. establish ERAD-engaging chimeras (ERADECs), a targeted protein degradation platform that redirects the endoplasmic reticulum quality-control pathway toward transmembrane proteins. By using desonide to engage the ER E3 ligase SYVN1, the study achieves highly effective PD-L1 degradation, tumor suppression, and initial extension to mutant HTT protein degradation.
-
Neurospora crassa IPA Pathway and Auxin Biosynthesis
2026-08-22
The Sardar and Kempken study provides the first integrated genetic and biochemical characterization of an indole-3-pyruvic acid pathway for indole-3-acetic acid production in the non-pathogenic fungus Neurospora crassa. Its combination of computational gene identification, metabolite profiling, and targeted knockouts shows how IPA flux contributes to fungal auxin production and conidiation.
-
Ceftolozane Resistance: PK/PD Modeling in P. aeruginosa
2026-08-21
Deroche and colleagues combined engineered Pseudomonas aeruginosa mutants, sequential time-kill experiments, and semi-mechanistic PK/PD modeling to separate constitutive from adaptive resistance to ceftolozane/tazobactam. The study shows that AmpC G183D and AmpD H157Y have distinct but synergistic effects, offering a quantitative framework for interpreting resistance that conventional MIC testing cannot fully resolve.
-
L-NAME Hydrochloride in Vascular Research
2026-08-20
L-NAME Hydrochloride provides a practical pharmacological switch for testing whether nitric oxide synthase contributes to vascular responses, hypertension phenotypes, or inflammatory cell behavior. Its greatest value emerges in pathway-mapping workflows that pair NOS inhibition with rescue experiments and orthogonal prostaglandin-receptor controls.
-
Pemetrexed: Reproducible Cell Assay Workflows
2026-08-20
Learn how Pemetrexed (SKU A4390) can support controlled cell viability, proliferation, and cytotoxicity studies through defined antifolate activity, documented solubility, and a practical in vitro concentration range. The article also explains assay design, interpretation, and vendor-selection considerations for cancer chemotherapy research.
-
DiscoveryProbe Natural Product Library Plus Guide
2026-08-19
The DiscoveryProbe Natural Product Library Plus is a 1,655-compound natural product library for HTS and HCS workflows. Its pre-dissolved DMSO format and analytical quality controls support reproducible natural product screening for drug discovery, including mechanistic studies motivated by Cryptosporidium parvum AdhE inhibition.
-
Indole-3-pyruvic acid: Assay Workflows
2026-08-19
Indole-3-pyruvic acid supports both mechanistic plant hormone research and targeted immune-cell assays. This guide converts its TAA1 feedback biology and AhR-linked activity into practical workflows, controls, and troubleshooting strategies.
-
Triazole ALDH2 Activators for Myocardial Ischemia
2026-08-18
This 2025 ACS Medicinal Chemistry Letters study used molecular simulation and structure-guided optimization to develop triazole aldehyde dehydrogenase 2 activators with improved activity and water solubility. Representative compound Z17 produced strong ALDH2 activation and improved cardiac and biochemical outcomes in a mouse myocardial ischemia–reperfusion model, while important translational limitations remain.
-
Nicotinamide Riboside Chloride in RGC Research
2026-08-18
Nicotinamide Riboside Chloride (NIAGEN) adds a controllable NAD+ metabolism variable to chemically defined retinal ganglion cell workflows. Used alongside dual SMAD and Wnt inhibition, it helps researchers distinguish lineage-generation effects from energy-homeostasis effects in metabolic and neurodegenerative disease models.
-
Cy3 NHS ester (non-sulfonated) Workflow Guide
2026-08-17
Cy3 NHS ester (non-sulfonated) provides an orange fluorescent handle for amino-group labeling of proteins, peptides, and amine-modified oligonucleotides or DNA. It is appropriate when a workflow can tolerate DMSO or DMF, but it should not be treated as a water-soluble reagent or used for direct aqueous labeling of solvent-sensitive biomolecules.
-
Latrunculin B: Reading Actin Perturbation
2026-08-17
Latrunculin B is more than an actin polymerization inhibitor: its transient, serum-sensitive behavior can sharpen interpretation of cytoskeletal and viral-entry assays. This guide connects molecular mechanism with the inhibitor-comparison strategy used in GCRV research.
-
Dynasore: Practical Endocytosis Workflow Guide
2026-08-16
Dynasore is a cell-permeable dynamin GTPase inhibitor for experimentally perturbing dynamin-dependent endocytosis, vesicle trafficking, and related cellular readouts. It is appropriate for controlled in vitro and cellular studies, but should not be treated as a universal dynamin-specific probe or as evidence for clinical efficacy.
-
Sulfo-NHS-Biotin for Single-Cell Assays
2026-08-15
Sulfo-NHS-Biotin converts primary-amine chemistry into a practical biotin handle for protein capture, cell-surface profiling, and modular single-cell assays. This guide translates nanovial-based functional screening into an actionable labeling workflow, with parameter choices and troubleshooting advice for preserving antigen activity and cell viability.
-
Optimizing Calcium Phosphate Transfection
2026-08-14
A 2026 study identifies the DNA concentration-to-reaction-volume balance as the main determinant of calcium phosphate transfection performance in HEK293T cells. Its optimized condition, 80 μg plasmid DNA in 1 mL for 2–3 × 10⁵ cells/mL, provides a practical starting point for improving an economical nonviral delivery method.